Test sell in AMGN strategy simulator at 284.45Testing a sell of AMGN in the strategy simulator, with first target at 270.49, second target at 260.85, and stop at 302.30
Key facts today
425 ARS
3.75 T ARS
30.43 T ARS
About Amgen Inc.
Sector
Industry
CEO
Robert A. Bradway
Website
Headquarters
Thousand Oaks
Founded
1980
ISIN
ARDEUT110665
FIGI
BBG000HDQXN6
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Related stocks
AMGN: the medicine cabinet for your portfolioOn the weekly chart, Amgen (AMGN) trades at $289.56, holding above the key $272–280 support zone, aligned with the 0.705–0.79 Fibo levels. This area forms a clear buy zone, where buyers are likely to step in. The technical structure remains bullish: the uptrend is intact, with targets at $346.85, ma
Utilizing algorithms to identify A+ trade opportunitiesMy typical video consists of analyzing a specific chart and telling its story. But here, I take a different approach and analyze how to actually capitalize on the knowledge we have through the algorithms.
As you'll see, these are repeated algorithms that we've identified from previous price actio
AMGN Long Trade Setup!📈
🕒 Timeframe: 30 min
🔻 Pattern: Falling wedge nearing breakout 🔼
📍 Entry Zone: ~$277.00 ✅
🎯 Target: $283.35 💰
🛑 Stop Loss: Below $274.00 ⚠️
🔥 Why It Looks Bullish:
🔺 Falling wedge structure — a known bullish pattern
🧱 Strong bounce off demand zone (support + yellow line)
💚 Green reversal candle
AMGN : Long with Good RR We are above the 200-period moving average on the 1-hour chart.
And the trend line has been broken.
There is a good risk - reward ratio. Approximately : 2.48
Small position sizes can be tried.
Entry : 287.38 (Now)
Stop - Loss : 276.28
Take Profit Level : 315.0
Regards.
AMGN Breakout Watch! 📈🧬
🔺 Triangle breakout after strong recovery 📊
🎯 Target: $287.98 | 🛑 Stop: $283.80
⚠️ Reversal from downtrend—momentum building fast! 🚀
💼 Chart analysis by #ProfittoPath 🔍
#AMGN #BiotechStocks #BreakoutTrade #TechnicalAnalysis #StockMarket
Amgen - V-shaped bottom at uptrend supportNASDAQ:AMGN is looking at a potential run up and given the positive momentum, the AMGN may break 289.97 resistance. The stock has broken above the overhead resistance and is likely to reach our 1st resistance at 309.57.
Furthermore, stochastic oscillator is showing oversold crossover and 23-perio
Pioneering Human Therapeutics $AMGNAmgen, Inc. is a biotechnology company that specializes in the discovery, development, manufacture, and marketing of human therapeutics. Founded on April 8, 1980, by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld, the company is headquartered in Thousa
The push toward 300A reset, as all indicators have retraced, and is ready to start moving after the consolidation stage.
AMGN short idea Simple head and shoulders on monthly timeframe, price is coming to our fair value sell on the weekly timeframe. price action is bearish on the daily. monthly fibs align with 240s price range.
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
AMGN.GA
Amgen Inc. 8.125% 01-APR-2097Yield to maturity
6.17%
Maturity date
Apr 1, 2097
US31162BP4
Amgen Inc. 5.375% 15-MAY-2043Yield to maturity
6.01%
Maturity date
May 15, 2043
US31162DU1
Amgen Inc. 5.75% 02-MAR-2063Yield to maturity
5.79%
Maturity date
Mar 2, 2063
US31162DG2
Amgen Inc. 4.4% 22-FEB-2062Yield to maturity
5.73%
Maturity date
Feb 22, 2062
US31162DK3
Amgen Inc. 4.875% 01-MAR-2053Yield to maturity
5.65%
Maturity date
Mar 1, 2053
US31162DT4
Amgen Inc. 5.65% 02-MAR-2053Yield to maturity
5.65%
Maturity date
Mar 2, 2053
AMGD
Amgen Inc. 4.2% 22-FEB-2052Yield to maturity
5.62%
Maturity date
Feb 22, 2052
US31162DN7
Amgen Inc. 5.507% 02-MAR-2026Yield to maturity
5.61%
Maturity date
Mar 2, 2026
AMGN4437315
Amgen Inc. 4.563% 15-JUN-2048Yield to maturity
5.60%
Maturity date
Jun 15, 2048
AMGN4436563
Amgen Inc. 4.663% 15-JUN-2051Yield to maturity
5.57%
Maturity date
Jun 15, 2051
US31162DS6
Amgen Inc. 5.6% 02-MAR-2043Yield to maturity
5.52%
Maturity date
Mar 2, 2043
See all AMGN bonds
Curated watchlists where AMGN is featured.
